Article Versions Notes

Tsuchiya K, Kurosaki M, Sakamoto A, Marusawa H, Kojima Y, Hasebe C, Arai H, Joko K, Kondo M, Tsuji K, et al. The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study. Cancers. 2021; 13(11):2608. https://doi.org/10.3390/cancers13112608

Tsuchiya, Kaoru, Masayuki Kurosaki, Azusa Sakamoto, Hiroyuki Marusawa, Yuji Kojima, Chitomi Hasebe, Hirotaka Arai, Kouji Joko, Masahiko Kondo, Keiji Tsuji, and et al. 2021. "The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study" Cancers 13, no. 11: 2608. https://doi.org/10.3390/cancers13112608

Tsuchiya, K., Kurosaki, M., Sakamoto, A., Marusawa, H., Kojima, Y., Hasebe, C., Arai, H., Joko, K., Kondo, M., Tsuji, K., Sohda, T., Kimura, H., Ogawa, C., Uchida, Y., Wada, S., Kobashi, H., Furuta, K., Shigeno, M., Kusakabe, A., ... on behalf of Japanese Red Cross Liver Study Group. (2021). The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study. Cancers, 13(11), 2608. https://doi.org/10.3390/cancers13112608